# A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)

> **NCT00701662** · PHASE2 · COMPLETED · sponsor: **CSL Behring** · enrollment: 8 (actual)

## Conditions studied

- Multifocal Motor Neuropathy (MMN)

## Interventions

- **BIOLOGICAL:** Vivaglobin

## Key facts

- **NCT ID:** NCT00701662
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2013-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701662, "A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00701662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*